China Life Insurance Company Limited has released its first-quarter 2025 financial results, demonstrating robust financial health and operational efficiency. The company’s total assets grew by 3.1% to reach a significant milestone, while equity attributable to equity holders increased by 4.5% compared to the end of 2024. Despite facing challenges that led to an 8.9% decrease in operating income, China Life Insurance achieved a remarkable 39.5% increase in net profit attributable to equity holders. This performance underscores the company’s strategic positioning in the insurance industry and its ability to navigate complex market conditions.
Company Overview
China Life Insurance Company Limited is a leading life insurance provider in China, offering a diverse range of insurance products and services. Incorporated in the People’s Republic of China, the company is listed on the Hong Kong Stock Exchange (HK:2628). As of the latest data, China Life Insurance has a market capitalization of $117.1 billion and an average trading volume of 9,673 shares.
Financial Highlights
- Total assets increased by 3.1% compared to the end of 2024
- Equity attributable to equity holders rose by 4.5%
- Net profit attributable to equity holders surged by 39.5%
- Operating income decreased by 8.9%
Market Performance
The stock has seen a year-to-date price performance of -1.08%. The current technical sentiment signal indicates a ‘Sell’ according to TipRanks’ analysis.
For more detailed analytics on China Life Insurance stock (2628), you can visit TipRanks’ Stock Analysis page.
